Sarepta Therapeutics Overview
Sarepta Therapeutics Target Price
Analysts' 12-month price predictions for SRPT.
Share Price
$39.54
Average Target Price
$110.00
178.2% upside
178.2% upside1 analysts in the last 4 months
High: $110 | Low: $110
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-21 | Piper Sandler | $110 | 178.2% upside |  |
| 2024-11-27 | Piper SandlerBiren Amin | $182 | 360.3% upside | |
| 2024-11-27 | NeedhamGil Blum | $202 | 410.9% upside | |
| 2024-11-07 | Robert W. BairdBrian Skorney | $193 | 388.1% upside | |
| 2024-11-07 | Cantor FitzgeraldKristen Kluska | $167 | 322.4% upside | |
| 2024-10-21 | JefferiesAndrew Tsai | $165 | 317.3% upside | |
| 2024-08-08 | Evercore ISIGavin Clark-Gartner | $179 | 352.7% upside | |
| 2024-08-08 | Piper SandlerBiren Amin | $200 | 405.8% upside | |
| 2024-08-08 | BarclaysGena Wang | $203 | 413.4% upside | |
| 2024-08-08 | RBC CapitalBrian Abrahams | $181 | 357.8% upside | |
| 2024-07-29 | RBC CapitalBrian Abrahams | $182 | 360.3% upside | |
| 2024-06-27 | BMO CapitalKostas Biliouris | $200 | 405.8% upside | |
| 2024-06-26 | Piper SandlerBiren Amin | $205 | 418.5% upside | |
| 2024-06-24 | Evercore ISIGavin Clark-Gartner | $185 | 367.9% upside | |
| 2024-06-24 | Mizuho SecuritiesUy Ear | $200 | 405.8% upside | |
| 2024-06-21 | Robert W. BairdBrian Skorney | $200 | 405.8% upside | |
| 2024-06-13 | Robert W. BairdBrian Skorney | $170 | 329.9% upside | |
| 2024-06-13 | Piper SandlerBiren Amin | $157 | 297.1% upside | |
| 2024-06-13 | BarclaysGena Wang | $185 | 367.9% upside | |
| 2024-06-07 | BMO CapitalKostas Biliouris | $170 | 329.9% upside | |
| 2024-05-28 | RBC CapitalBrian Abrahams | $142 | 259.1% upside | |
| 2024-05-20 | RBC CapitalBrian Abrahams | $157 | 297.1% upside | |
| 2024-05-17 | Mizuho SecuritiesUy Ear | $179 | 352.7% upside | |
| 2024-05-14 | OppenheimerHartaj Singh | $180 | 355.2% upside | |
| 2024-05-06 | Morgan StanleyMatthew Harrison | $165 | 317.3% upside | |
| 2024-05-02 | RBC CapitalBrian Abrahams | $141 | 256.6% upside | |
| 2023-03-01 | Morgan StanleyMatthew Harrison | $187 | 372.9% upside | |
| 2023-01-10 | Credit Suisse | $114 | 188.3% upside | |
| 2023-01-10 | Needham | $160 | 304.7% upside | |
| 2022-12-22 | BTIG | $160 | 304.7% upside | |
| 2022-12-16 | UBS | $158 | 299.6% upside | |
| 2022-11-03 | NeedhamGil Blum | $158 | 299.6% upside | |
| 2022-09-08 | Morgan Stanley | $135 | 241.4% upside | |
| 2022-08-15 | OppenheimerHartaj Singh | $150 | 279.4% upside | |
| 2022-08-03 | Morgan Stanley | $100 | 152.9% upside | |
| 2022-07-29 | Needham | $162 | 309.7% upside | |
| 2022-07-15 | Morgan Stanley | $80 | 102.3% upside | |
| 2022-05-24 | Goldman Sachs | $155 | 292% upside | |
| 2022-03-02 | Berenberg BankZhiqiang Shu | $94 | 137.7% upside | |
| 2022-03-02 | NeedhamGil Blum | $150 | 279.4% upside | |
| 2022-01-10 | Mizuho SecuritiesUy Ear | $160 | 304.7% upside | |
| 2022-01-05 | BTIGYun Zhong | $125 | 216.1% upside | |
| 2022-01-04 | OppenheimerHartaj Singh | $125 | 216.1% upside | |
| 2021-10-15 | Credit SuisseJudah Frommer | $95 | 140.3% upside | |